ALISO VIEJO, Calif.--(BUSINESS WIRE)--AVANIR Pharmaceuticals (NASDAQ: AVNR) today announced that it has received notification from NASDAQ that it has regained compliance with listing standards required to maintain its listing on the NASDAQ Global Market.
